 | Maxim Group Reiterates "Reduce" Rating for Horizon Therapeutics Public (NASDAQ:HZNP)
marketbeat.com - May 27 at 8:41 AM |
 | Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) Shares Could Be 42% Below Their Intrinsic Value Estimate
finance.yahoo.com - June 8 at 11:48 AM |
 | Zacks: Analysts Anticipate Horizon Therapeutics Public Limited (NASDAQ:HZNP) to Post $0.93 Earnings Per Share
americanbankingnews.com - June 6 at 1:18 AM |
| Horizon Therapeutics plc Presents New Data on Robust Pipeline at EULAR European Congress of Rheumatology
finance.yahoo.com - June 2 at 8:05 AM |
| Horizon Therapeutics plc Initiates ADVANCE Trial Evaluating KRYSTEXXA® (pegloticase injection) with Methotrexate for People Who Previously Developed Anti-Drug Antibodies on KRYSTEXXA Monotherapy
finance.yahoo.com - May 27 at 12:41 PM |
| Horizon Therapeutics Public (NASDAQ:HZNP) Given Reduce Rating at Maxim Group
americanbankingnews.com - May 27 at 10:10 AM |
 | Is There An Opportunity With Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) 40% Undervaluation?
nasdaq.com - May 24 at 2:15 PM |
| Horizon Therapeutics Public (NASDAQ:HZNP) Sets New 12-Month High at $97.34
americanbankingnews.com - May 24 at 1:12 PM |
|
| Horizon Therapeutics plc Highlights Expanding R&D Efforts with Data Presentations at the EULAR European Congress of Rheumatology
finance.yahoo.com - May 21 at 10:42 AM |
| Horizon Therapeutics plc Named One of the 2021 Best Workplaces in Chicago™ by Great Place to Work®
finance.yahoo.com - May 20 at 12:32 PM |
| Horizon Therapeutics plc to Present at the Bank of America Securities 2021 Health Care Conference
finance.yahoo.com - May 6 at 5:16 PM |
| New Analysis of UPLIZNA® (inebilizumab-cdon) for Neuromyelitis Optica Spectrum Disorder (NMOSD) Published in Neurology Neuroimmunology & Neuroinflammation
finance.yahoo.com - May 6 at 12:15 PM |
 | Horizon Therapeutics Public Limited Company 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 5 at 3:08 PM |
 | Horizon Therapeutics (HZNP) Misses Q1 Earnings Estimates
msn.com - May 5 at 11:06 AM |
| Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.
finance.yahoo.com - May 5 at 11:06 AM |
| Was The Smart Money Right About Horizon Therapeutics (HZNP)?
finance.yahoo.com - May 4 at 2:29 PM |
| We Think Shareholders Will Probably Be Generous With Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) CEO Compensation
nasdaq.com - April 24 at 2:44 PM |
| We Take A Look At Why Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) CEO Has Earned Their Pay Packet
finance.yahoo.com - April 24 at 2:44 PM |
| Does Horizon Therapeutics (NASDAQ:HZNP) Have A Healthy Balance Sheet?
nasdaq.com - April 21 at 1:49 PM |
| HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
finance.yahoo.com - April 21 at 8:49 AM |
| New Integrated Data and Follow-up Outcomes From Two TEPEZZA® (teprotumumab-trbw) Pivotal Trials Published in The Lancet Diabetes & Endocrinology
finance.yahoo.com - April 16 at 9:04 AM |
| New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
finance.yahoo.com - April 16 at 9:04 AM |
| Biotech Stock On Earnings Win Streak Sets Up Bullish Chart
finance.yahoo.com - April 12 at 7:16 PM |
| Horizon Therapeutics plc Named One of the Fortune 100 Best Companies to Work For®
finance.yahoo.com - April 12 at 9:14 AM |
|
| Horizon Therapeutics plc to Release First-Quarter 2021 Financial Results and Host Webcast on May 5, 2021
finance.yahoo.com - April 8 at 9:07 AM |
| RECIPE Randomized Controlled Trial Data Published in Arthritis & Rheumatology Show Higher Response Rates Using KRYSTEXXA® (pegloticase injection) with the Immunomodulator Mycophenolate Mofetil
finance.yahoo.com - April 7 at 8:12 AM |
| New UPLIZNA® (inebilizumab-cdon) Data in People With Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the American Academy of Neurology’s 73rd Annual Meeting
finance.yahoo.com - April 5 at 1:23 PM |
| Horizon Therapeutics plc to Resupply Market With TEPEZZA® (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) Beginning in April
finance.yahoo.com - March 30 at 8:57 AM |
| Is Horizon Therapeutics (HZNP) A Good Stock to Short?
finance.yahoo.com - March 25 at 1:57 PM |
| First Patient Enrolls in FORWARD Trial to Evaluate Monthly Dosing of KRYSTEXXA® (pegloticase injection) and Methotrexate to Treat Uncontrolled Gout
finance.yahoo.com - March 25 at 8:54 AM |
| Horizon Therapeutics plc Launches The Horizon Prize with Massachusetts Institute of Technology (MIT) Solve to Advance Solutions for the Rare Disease Community
finance.yahoo.com - March 24 at 9:31 AM |
| UPLIZNA® (inebilizumab-cdon) Approved by Japanese Ministry of Health, Labour and Welfare for the Prevention of Relapses of Neuromyelitis Optica Spectrum Disorder (NMOSD)
finance.yahoo.com - March 24 at 9:31 AM |
| Is HZNP Stock A Buy or Sell?
finance.yahoo.com - March 23 at 1:29 PM |
| Horizon Therapeutics Public Limited Company's (NASDAQ:HZNP) Stock Is Going Strong: Have Financials A Role To Play?
finance.yahoo.com - March 22 at 12:17 PM |
| Horizon Therapeutics plc Completes Acquisition of Viela Bio, Inc.
finance.yahoo.com - March 15 at 10:02 AM |
| Horizon Therapeutics plc Named Number One Best Workplace in Biopharma
finance.yahoo.com - March 12 at 5:40 PM |
| Horizon Therapeutics plc Named as One of the Best Workplaces in Ireland
finance.yahoo.com - March 11 at 4:59 AM |
| Biotech stocks are a buy — especially these 18 picks
finance.yahoo.com - March 9 at 1:37 PM |
| Horizon Therapeutics Pivots Towards Explosive Earnings Growth
finance.yahoo.com - March 8 at 2:21 PM |
| Horizon Therapeutics plc to Present at the Cowen and Company 41st Annual Health Care Conference
finance.yahoo.com - February 26 at 5:45 PM |
| Why Horizon Therapeutics Stock Jumped Today
msn.com - February 25 at 12:48 AM |
| Why Horizon Therapeutics's Stock is Trading Higher Today
msn.com - February 24 at 2:47 PM |
| Horizon Posts Triple-Digit Sales Growth After Adding Tepezza To Lineup
finance.yahoo.com - February 24 at 2:47 PM |
| Horizon Therapeutics plc Reports Record Fourth-Quarter and Full-Year 2020 Financial Results; Announces Full-Year 2021 Guidance
finance.yahoo.com - February 24 at 9:47 AM |
| Horizon's 'Breakthrough Year' Ends With Fourth-Quarter Earnings Beat
finance.yahoo.com - February 24 at 9:47 AM |
| New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic Phase
finance.yahoo.com - February 22 at 9:37 AM |
| Horizon Therapeutics (HZNP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
msn.com - February 19 at 7:49 PM |
| Inovio Pharmaceuticals Shows Market Leadership With Jump To 86 RS Rating
finance.yahoo.com - February 18 at 1:21 PM |
| Horizon Pharma Shows Rising Price Performance With Jump To 85 RS Rating
finance.yahoo.com - February 3 at 4:31 PM |
| Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2020 Financial Results and Host Webcast on Feb. 24, 2021
finance.yahoo.com - February 3 at 11:31 AM |
| SHAREHOLDER ALERT: WeissLaw LLP Investigates Viela Bio, Inc.
finance.yahoo.com - February 1 at 4:36 PM |
